# FDA recall Z-1430-2020

> **Normand-Info S.A.S.U.** · Class II · device recall initiated 2019-08-15.

## Product

Remisol Advance running on hardware with Windows XP, Windows 7, Windows Server 2003 and Windows Server 2008 operating systems

## Reason for recall

A patch was released for a critical remote code execution vulnerability in remote desktop services. This vulnerability can be exploited remotely without authentication on certain operating systems. An attacker who successfully exploited this vulnerability could execute arbitrary code on the target system; then install programs; view, change, or delete data; or create new accounts with full user rights. If the vulnerability could be exploited locally, it would lock down the computer.

## Distribution

U.S.: NY, AZ, FL, NJ, MA, OH, CA, IL, NC, OK, IN, KY, OR, MI, WI, PA, UT, GA, VA, TX, NE, SD, IA, MN, MD, DE, SC, MT, WV, LA, MO, TN, NM, NV, HI, WA, WY, AL, AR, MS, RI, ID, ME, DC, ND, AK, CO, CT, KS, NH, VT

## Key facts

- **Recall number:** Z-1430-2020
- **Recalling firm:** Normand-Info S.A.S.U.
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2019-08-15
- **Report date:** 2020-03-11
- **Termination date:** 2021-06-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Arras CEDEX, N/A, France

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1430-2020

## Citation

> AI Analytics. FDA recall Z-1430-2020. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/Z-1430-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*